BMS lending duo win again in $63bn AbbVie deal
The loan desks at Morgan Stanley and MUFG are big winners in AbbVie’s around $63bn purchase of Botox maker Allergan, with the banks picked to provide more than half of the purchase price in underwritten debt.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: